What is CABA's relative strength rating?

CABA ranks at the 79th percentile over 1 month, 24th percentile over 3 months, 57th percentile over 6 months, 90th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is CABA in?

CABA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is CABA in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CABA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is CABA?

CABA currently shows a 20-day average daily range (ADR%) of 5.9%, a 90-day beta versus the S&P 500 of 0.66. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does CABA have a seasonal pattern?

TickerStance computes CABA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CABA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did CABA last report earnings?

CABA most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Cabaletta Bio, Inc. Common Stock (CABA) · RS 57

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Cabaletta Bio, Inc. Common Stock (CABA) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.9%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month24pctile

6 month57pctile

1 year90pctile

Classic72IBD pctile

LDR60leadership

0 of 5 lenses lit · avg RS pctile 61

✓ADR%5.9%✓A/DA!RVOL0.78×✓$ Vol$14M

COMPUTED · AS OF 2026-08-24

Pattern read

CABA is in a stage 3 topping pattern, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 7.6% / 8.0%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

2 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

79

3m

24

6m

57

1y

90

LDR

—

StageWeinstein stage analysis

Stage 3 · Topping

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · CABA

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

EDGAR quarterly revenue basics absent: EPS quarterly facts present, no usable quarterly revenue series

View fundamental leadership map

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.62—

24 Q3

−$0.65—

24 Q4

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
CABA
24RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

ASNDAscendis Pharma A/S Ordinary Share58 CTNMContineum Therapeutics, Inc. Class A Common Stock57 PRAXPraxis Precision Medicines, Inc. Common Stock58 PCRXPacira BioSciences, Inc. Common Stock58

§ Seasonality

10y · since 2022

Best monthOct on averageavg +45.78% · 50% win · n 4

Worst monthMar on averageavg -18.53% · 0% win · n 4

CABA monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	CABA Jan avg: 11.16% median: 11.32% win: 75% σ: 17.67% n: 4 2022-04-12 → 2026-07-31	CABA Feb avg: -2.76% median: -6.38% win: 50% σ: 27.77% n: 4 2022-04-12 → 2026-07-31	CABA Mar avg: -18.53% median: -21.12% win: 0% σ: 8.49% n: 4 2022-04-12 → 2026-07-31	CABA Apr avg: -6.44% median: -4.69% win: 40% σ: 26.03% n: 5 2022-04-12 → 2026-07-31	CABA May avg: 10.76% median: -2.79% win: 40% σ: 21.99% n: 5 2022-04-12 → 2026-07-31	CABA Jun avg: -10.46% median: -17.72% win: 20% σ: 21.80% n: 5 2022-04-12 → 2026-07-31	CABA Jul avg: -0.42% median: 0.00% win: 40% σ: 9.68% n: 5 2022-04-12 → 2026-07-31	CABA Aug avg: -10.11% median: -11.84% win: 25% σ: 11.85% n: 4 2022-04-12 → 2026-07-31 (current)	CABA Sep avg: 5.20% median: -4.34% win: 50% σ: 40.81% n: 4 2022-04-12 → 2026-07-31	CABA Oct avg: 45.78% median: 23.98% win: 50% σ: 83.27% n: 4 2022-04-12 → 2026-07-31	CABA Nov avg: 39.11% median: 10.08% win: 75% σ: 85.99% n: 4 2022-04-12 → 2026-07-31	CABA Dec avg: 23.14% median: 13.32% win: 50% σ: 65.26% n: 4 2022-04-12 → 2026-07-31

ETF OWNERS

ETFs holding CABA

CABA is held by 3 ETFs as of May 2026. Top owner: AVSC at 0.00% weight, $66K notional. Top 3 carry $98K.

Held by 12 ETFs · $15M across latest filings · largest weight 0.58% (TMED).

ETFs holding: 3
Total value: $98K
Top 3 concentration: 100.0%
Max weight: IBBQ · 0.03%

Top 3 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding CABA ranked by value
ETF	Weight	Value	Δ
AVSC	0.00%	$66K	—
IBBQ	0.03%	$19K	—
BIB	0.02%	$13K	—

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · CABA

Is the crowd watching?

44/ 100 · vs its own 90-day norm▼ 13 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2836

Float136.8Mshares

Shares out169.5Mshares

Market cap$525.6MSmall Cap

FAQ

Frequently asked questions

What is CABA's relative strength rating?: CABA ranks at the 79th percentile over 1 month, 24th percentile over 3 months, 57th percentile over 6 months, 90th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is CABA in?: CABA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is CABA in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CABA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is CABA?: CABA currently shows a 20-day average daily range (ADR%) of 5.9%, a 90-day beta versus the S&P 500 of 0.66. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does CABA have a seasonal pattern?: TickerStance computes CABA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CABA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Cabaletta Bio, Inc. Common Stock (CABA) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding CABA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

Cabaletta Bio, Inc. Common Stock (CABA) — Stance & relative strength

CABA is not confirmed as a leader. 24 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding CABA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?